Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by HEATH SKINNER and JAN KEMNADE.
HEATH SKINNER
Connection Strength
0.329
JAN KEMNADE
  1. Phase I / II trial of metformin as a chemo-radiosensitizer in a head and neck cancer patient population. Oral Oncol. 2023 10; 145:106536.
    View in: PubMed
    Score: 0.228
  2. Oropharyngeal cancer outcomes correlate with p16 status, multinucleation and immune infiltration. Mod Pathol. 2022 08; 35(8):1045-1054.
    View in: PubMed
    Score: 0.052
  3. Metformin generates profound alterations in systemic and tumor immunity with associated antitumor effects. J Immunother Cancer. 2021 07; 9(7).
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.